Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies
TT Lai, B Gericke, M Feja, M Conoscenti… - npj Parkinson's …, 2023 - nature.com
Synucleinopathies are neurodegenerative disorders characterized by alpha-synuclein
(αSyn) accumulation in neurons or glial cells, including Parkinson's disease (PD), dementia …
(αSyn) accumulation in neurons or glial cells, including Parkinson's disease (PD), dementia …
Parkinson's disease: exploring different animal model systems
Disease modeling in non-human subjects is an essential part of any clinical research. To
gain proper understanding of the etiology and pathophysiology of any disease, experimental …
gain proper understanding of the etiology and pathophysiology of any disease, experimental …
Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism
D Masini, O Kiehn - Nature communications, 2022 - nature.com
The pedunculopontine nucleus (PPN) is a locomotor command area containing
glutamatergic neurons that control locomotor initiation and maintenance. These motor …
glutamatergic neurons that control locomotor initiation and maintenance. These motor …
Unilateral intrastriatal 6-hydroxydopamine lesion in mice: a closer look into non-motor phenotype and glial response
Parkinson's disease (PD) is a prevalent movement disorder characterized by the
progressive loss of dopaminergic neurons in substantia nigra pars compacta (SNpc). The 6 …
progressive loss of dopaminergic neurons in substantia nigra pars compacta (SNpc). The 6 …
[HTML][HTML] A mouse model of sleep disorders in Parkinson's disease showing distinct effects of dopamine D2-like receptor activation
D de Castro Medeiros, C Plewnia, RV Mendes… - Progress in …, 2023 - Elsevier
Excessive daytime sleepiness (EDS) and sleep fragmentation are often observed in
Parkinson's disease (PD) patients and are poorly understood despite their considerable …
Parkinson's disease (PD) patients and are poorly understood despite their considerable …
Targeting mitochondria with small molecules: A promising strategy for combating Parkinson's disease
C Pal - Mitochondrion, 2024 - Elsevier
Abstract Parkinson's disease (PD), a neurodegenerative disorder, is one of the most
significant challenges confronting modern societies, affecting millions of patients globally …
significant challenges confronting modern societies, affecting millions of patients globally …
Neuroprotective effects of microRNA 124 in Parkinson's disease mice
F Zhang, Y Yao, N Miao, N Wang, X Xu… - Archives of Gerontology …, 2022 - Elsevier
Background: Recent studies have revealed the close correlation between microRNAs
(miRs) and Parkinson's disease (PD). Here, we aimed to investigate the neuroprotective …
(miRs) and Parkinson's disease (PD). Here, we aimed to investigate the neuroprotective …
ARL6IP5 ameliorates α-synuclein burden by inducing autophagy via preventing ubiquitination and degradation of ATG12
Recent advanced studies in neurodegenerative diseases have revealed several links
connecting autophagy and neurodegeneration. Autophagy is the major cellular degradation …
connecting autophagy and neurodegeneration. Autophagy is the major cellular degradation …
Serotonergic and dopaminergic neurons in the dorsal raphe are differentially altered in a mouse model for parkinsonism
Parkinson's disease (PD) is characterized by motor impairments caused by degeneration of
dopamine neurons in the substantia nigra pars compacta. In addition to these symptoms, PD …
dopamine neurons in the substantia nigra pars compacta. In addition to these symptoms, PD …
The 6-hydroxydopamine rat model of Parkinson's disease
Motor symptoms of Parkinson's disease (PD)-bradykinesia, akinesia, and tremor at rest-are
consequences of the neurodegeneration of dopaminergic neurons in the substantia nigra …
consequences of the neurodegeneration of dopaminergic neurons in the substantia nigra …